Johnson and Johnson accelerates drug development with artificial intelligence

publicat 2026-04-29 00:00:13 (Bursa)
American pharmaceutical giant Johnson and Johnson is increasingly relying on artificial intelligence to significantly reduce the time required to research and develop new treatments, at a time when the PHARMACEUTICAL INDustry is looking for solutions to shorten extremely expensive and time-consuming processes. According to the company and #39;s IT director, Jim Swanson, quoted by Reuters, AI has already managed to halve the time required to identify... ...continuare.
EMAG
pharmaceutical ind cath leonardo d goodbye cine se poate standarde motor pro escrocherie idea timi senators dan andrei bejan teste fran brie netfli caimac teraplast rani da e adeplast etaru meserii romtelecom aur romanesc ing dan vista en vine frigul atacul medicam avertizarea zeki consiliul consultativ imors rados pasti 2026 tumori huawei se technology martinez a calculat vesti proaste hrana viata e frumoasa cladiri politica de pre e contab a ban blenche



© Copyright 2000-2026 iStorm. Toate drepturile rezervate.